4.3 Review

Brimonidine and brinzolamide for treating glaucoma and ocular hypertension; a safety evaluation

Related references

Note: Only part of the references are listed.
Article Pharmacology & Pharmacy

Liposomes as a Novel Ocular Delivery System for Brinzolamide: In Vitro and In Vivo Studies

Huili Li et al.

AAPS PHARMSCITECH (2016)

Review Biochemistry & Molecular Biology

Drug interaction considerations in the therapeutic use of carbonic anhydrase inhibitors

Claudiu T. Supuran

EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2016)

Review Pharmacology & Pharmacy

Emerging drugs to treat glaucoma: targeting prostaglandin F and E receptors

Jed Asher Lusthaus et al.

EXPERT OPINION ON EMERGING DRUGS (2016)

Article Ophthalmology

Acetazolamide-Related Life-Threatening Hypophosphatemia in a Glaucoma Patient

Ching-Yun Hu et al.

JOURNAL OF GLAUCOMA (2015)

Review Primary Health Care

Glaucoma

Anand V. Mantravadi et al.

PRIMARY CARE (2015)

Review Biotechnology & Applied Microbiology

Ocular Blood Flow and Normal Tension Glaucoma

Ning Fan et al.

BIOMED RESEARCH INTERNATIONAL (2015)

Article Ophthalmology

Migraine and Vasospasm in Glaucoma: Age-Related Evaluation of 2027 Patients With Glaucoma or Ocular Hypertension

Gwendolyn Gramer et al.

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2015)

Article Ophthalmology

Factors associated with lifetime risk of open-angle glaucoma blindness

Dorothea Peters et al.

ACTA OPHTHALMOLOGICA (2014)

Review Ophthalmology

Glaucoma in pregnancy

Sarwat Salim

CURRENT OPINION IN OPHTHALMOLOGY (2014)

Review Medicine, General & Internal

Combination of brinzolamide and brimonidine for glaucoma and ocular hypertension: critical appraisal and patient focus

Quang H. Nguyen

PATIENT PREFERENCE AND ADHERENCE (2014)

Review Pharmacology & Pharmacy

Glaucoma management: relative value and place in therapy of available drug treatments

Deepak Sambhara et al.

THERAPEUTIC ADVANCES IN CHRONIC DISEASE (2014)

Article Ophthalmology

Evaluation of Adverse Events in Self-Reported Sulfa-Allergic Patients Using Topical Carbonic Anhydrase Inhibitors

Guilherme B. Guedes et al.

JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2013)

Article Ophthalmology

Phase 3 Randomized 3-Month Trial with an Ongoing 3-Month Safety Extension of Fixed-Combination Brinzolamide 1%/Brimonidine 0.2%

Quang H. Nguyen et al.

JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2013)

Article Ophthalmology

Ocular Surface Disease and Quality of Life in Patients With Glaucoma

Simon E. Skalicky et al.

AMERICAN JOURNAL OF OPHTHALMOLOGY (2012)

Article Ophthalmology

Global estimates of visual impairment: 2010

Donatella Pascolini et al.

BRITISH JOURNAL OF OPHTHALMOLOGY (2012)

Article Ophthalmology

Update on the role of alpha-agonists in glaucoma management

Stella Arthur et al.

EXPERIMENTAL EYE RESEARCH (2011)

Review Medicine, General & Internal

Objective assessment of compliance and persistence among patients treated for glaucoma and ocular hypertension: a systematic review

Gregory Reardon et al.

PATIENT PREFERENCE AND ADHERENCE (2011)

Article Ophthalmology

Exposure to Topical Apraclonidine in Children With Glaucoma

Tarra M. Wright et al.

JOURNAL OF GLAUCOMA (2009)

Article Medicine, General & Internal

Brimonidine-purite 0.1% versus brimonidine-purite 0.15% twice daily in glaucoma or ocular hypertension: a 12-month randomized trial

Louis B. Cantor et al.

CURRENT MEDICAL RESEARCH AND OPINION (2008)

Review Geriatrics & Gerontology

Pharmacological management of primary open-angle glaucoma - Second-line options and beyond

Carroll A. B. Webers et al.

DRUGS & AGING (2008)

Article Ophthalmology

Brimonidine-induced anterior uveitis and conjunctivitis clinical and histologic features

Ethan V. Nguyen et al.

JOURNAL OF GLAUCOMA (2008)

Review Biotechnology & Applied Microbiology

Carbonic anhydrases: novel therapeutic applications for inhibitors and activators

Claudiu T. Supuran

NATURE REVIEWS DRUG DISCOVERY (2008)

Article Ophthalmology

The course of glaucoma during pregnancy - A retrospective case series

Stacey C. Brauner et al.

ARCHIVES OF OPHTHALMOLOGY (2006)

Article Ophthalmology

Topical brinzolamide and metabolic acidosis

GJ Menon et al.

BRITISH JOURNAL OF OPHTHALMOLOGY (2006)

Article Pharmacology & Pharmacy

Is brimonidine ophthalmic a safe therapy for infants?

G. P. Daubert

JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2006)

Article Ophthalmology

Brinzolamide induced reversible corneal decompensation

JC Zhao et al.

BRITISH JOURNAL OF OPHTHALMOLOGY (2005)

Article Medicine, General & Internal

Absence of cross-reactivity between sulfonamide antibiotics and sulfonamide nonantibiotics

BL Strom et al.

NEW ENGLAND JOURNAL OF MEDICINE (2003)

Letter Ophthalmology

Topical dorzolamide and metabolic acidosis in a neonate

S Morris et al.

BRITISH JOURNAL OF OPHTHALMOLOGY (2003)

Review Ophthalmology

Prostaglandin-induced hair growth

MA Johnstone et al.

SURVEY OF OPHTHALMOLOGY (2002)

Article Ophthalmology

Allergic reactions to brimonidine in patients treated for glaucoma

P Blondeau et al.

CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE (2002)

Article Ophthalmology

The definition and classification of glaucoma in prevalence surveys

PJ Foster et al.

BRITISH JOURNAL OF OPHTHALMOLOGY (2002)

Article Pediatrics

Ophthalmic drops causing coma in an infant

RJ Berlin et al.

JOURNAL OF PEDIATRICS (2001)

Review Ophthalmology

Management of glaucoma in pregnancy and lactation

SM Johnson et al.

SURVEY OF OPHTHALMOLOGY (2001)

Review Ophthalmology

Preclinical overview of brinzolamide

L DeSantis

SURVEY OF OPHTHALMOLOGY (2000)